img_9496-2François BOUTIGNON, President and CEO.

After a post-doc in Oxford, François joined EUROPEPTIDES (BU of Mediolanum then ASTA MEDICA) where he held the position of VP R&D. During this years, Francois developed several peptide based products among which injectable depots of GnRH agonists and antagonists (biodegradable implants, microspheres, microcrystals). Francois co-founded APTYS Pharmaceuticals in 2002 after the acquisition of patents rights on delivery technology from the University of Auvergne.


Mmichel-eichel FRADIN, Responsible Pharmacist and COO

Michel holds a Doctorate in Pharmacy and a PhD in Pharmaco-Chemistry. He has 26 years of  international pharmaceutical industry experience.
At MERCK SHARP & DOHME, his main positions were Head of Pharmaceutical Technical Operations Department, Responsible Pharmacist and Regional Business Operations Director (Europe Middle East Africa).




Luc is a certified Accountant and holds a Master in Business Procedural Law.
He has more than 32 years of experience in finance, including corporate finance, audit and fund raising.
He worked with several Accounting firms such as KPMG and COFEXCE. In 1994, he founded his own firm.